Regulatory B cells correlate with HIV disease progression

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• Interleukin-10 (IL-10)-producing regulatory B cells (Breg) are a rare subset identified in humans and mice.
• Unified cell surface markers for Breg identification are lacking.
• The association between Breg frequency and HIV disease progression in chronic infection remains unclear.

Purpose of the Study:

• To evaluate the suitability of previously reported Breg cell surface markers for identifying Breg cells in HIV-infected patients.
• To investigate the relationship between Breg cell frequency and HIV disease progression.

Main Methods:

• Analysis of cell surface markers to identify Breg cells in HIV-infected patients.
• Correlation analysis between Breg frequency, viral load, and CD4+ T cell counts.
• Assessment of Breg frequency and CD4+ T cell counts before and after antiretroviral therapy (ART).
• Evaluation of IL-10 expression in CD1d(hi) and CD1d(lo) cells from HIV-infected patients.

Main Results:

• Breg cell frequency positively correlated with HIV viral load and negatively with CD4+ T cell counts in chronic infection.
• Antiretroviral treatment led to a stepwise increase in CD4+ T cell counts and a decrease in Breg cell frequency.
• No significant difference in IL-10 expression was observed between CD1d(hi) and CD1d(lo) cells in HIV-infected individuals.

Conclusions:

• Breg cell frequency is a potential indicator of HIV disease progression and response to antiretroviral therapy.
• CD1d is not a reliable marker for identifying Breg cells in the context of HIV infection.